tirzepatide weight loss studies after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial Tirzepatide once weekly for the

Steadier, more sustainable weight management when paired with diet and lifestyle changes

What if that irresistible pull isn't just

This product description is for informational purposes only and does not constitute medical advice

We at Pomegranate Health recognize the concern and stress caused by the unavailability of critical medications such as Mounjaro and Zepbound

New research suggests the risks tied to early pregnancy exposure to popular weight loss drugs may not be the same for every patient.

Co-primary endpoints were changes from baseline to end of treatment in the first (AUC010 min) and second (AUC10120 min) insulin secretion phases, as measured by the IVGTT